Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

SuperGen expands phase III trials of RFS-2000 in pancreatic cancer

Sep. 17, 1998

Inhibitors of telomerase focus of investigation at CRC Technology, U. Texas

Sep. 17, 1998

Novel treatment for breast cancer available for licensing

Sep. 16, 1998

Lilly discovers inhibitors of PSA enzymatic activity for cancer, BPH

Sep. 16, 1998

Anthraquinone telomerase inhibitors developed at CRC Technology

Sep. 16, 1998

Positive clinical data from temozolomide trials presented at European oncology meeting

Sep. 16, 1998

Matrix completes enrollment in IntraDose trials

Sep. 16, 1998

Corixa's MUC-1 vaccine technology receives patent protection

Sep. 16, 1998

Hycamtin receives first approval for small cell lung cancer in Switzerland

Sep. 15, 1998

Onyx discovers another therapeutic virus for cancer therapy

Sep. 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...